We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
159 hedge funds and large institutions have $166M invested in Fate Therapeutics in 2024 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 45 increasing their positions, 47 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
133% more call options, than puts
Call options by funds: $91K | Put options by funds: $39K
4% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 47
3% less funds holding
Funds holding: 164 → 159 (-5)
11.48% less ownership
Funds ownership: 100.77% → 89.29% (-11%)
13% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 40
59% less capital invested
Capital invested by funds: $402M → $166M (-$235M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
159
Holders Change
-5
Holders Change %
-3.05%
% of All Funds
2.09%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
35
Increased
45
Reduced
47
Closed
40
Calls
$91K
Puts
$39K
Net Calls
+$52K
Net Calls Change
-$152K
Top Buyers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$7.68M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$2.91M |
| 3 |
Walleye Capital
New York
|
+$2.56M |
| 4 |
Cerity Partners
New York
|
+$2.03M |
| 5 |
VPC
Vestal Point Capital
New York
|
+$1.97M |
Top Sellers
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$19.5M |
| 2 |
State Street
Boston,
Massachusetts
|
-$7.62M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$5.19M |
| 4 |
D.E. Shaw & Co
New York
|
-$4.64M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$4.14M |
